| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | endopeptidase activity | TMPRSS9 PRSS3 KLK10 AZU1 PRSS56 PGC F7 CAPN13 ADAMTS7 PRSS27 CAPN7 PARL CTSB CTSK CTSL CTSV MASP2 | 1.79e-10 | 430 | 109 | 17 | GO:0004175 |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | TMPRSS9 PRSS3 KLK10 AZU1 PRSS56 F7 PRSS27 PARL CTSK CTSV MASP2 | 7.39e-09 | 190 | 109 | 11 | GO:0004252 |
| GeneOntologyMolecularFunction | serine-type peptidase activity | TMPRSS9 PRSS3 KLK10 AZU1 PRSS56 F7 PRSS27 PARL CTSK CTSV MASP2 | 1.80e-08 | 207 | 109 | 11 | GO:0008236 |
| GeneOntologyMolecularFunction | serine hydrolase activity | TMPRSS9 PRSS3 KLK10 AZU1 PRSS56 F7 PRSS27 PARL CTSK CTSV MASP2 | 2.30e-08 | 212 | 109 | 11 | GO:0017171 |
| GeneOntologyMolecularFunction | peptidase activity | TMPRSS9 PRSS3 KLK10 AZU1 PRSS56 PGC F7 CAPN13 ADAMTS7 PRSS27 CAPN7 PARL CTSB CTSK CTSL CTSV MASP2 | 9.22e-08 | 654 | 109 | 17 | GO:0008233 |
| GeneOntologyMolecularFunction | kininogen binding | 1.57e-06 | 5 | 109 | 3 | GO:0030984 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 1.57e-06 | 5 | 109 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 7.60e-06 | 86 | 109 | 6 | GO:0004197 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 8.50e-06 | 51 | 109 | 5 | GO:0043394 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 2.81e-05 | 65 | 109 | 5 | GO:0004714 | |
| GeneOntologyMolecularFunction | serpin family protein binding | 2.95e-05 | 2 | 109 | 2 | GO:0097655 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.02e-04 | 85 | 109 | 5 | GO:0019199 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.45e-04 | 145 | 109 | 6 | GO:0004713 | |
| GeneOntologyMolecularFunction | cysteine-type carboxypeptidase activity | 1.76e-04 | 4 | 109 | 2 | GO:0016807 | |
| GeneOntologyMolecularFunction | glucokinase activity | 2.92e-04 | 5 | 109 | 2 | GO:0004340 | |
| GeneOntologyMolecularFunction | hexokinase activity | 2.92e-04 | 5 | 109 | 2 | GO:0004396 | |
| GeneOntologyMolecularFunction | fructokinase activity | 2.92e-04 | 5 | 109 | 2 | GO:0008865 | |
| GeneOntologyMolecularFunction | protein-lysine 6-oxidase activity | 2.92e-04 | 5 | 109 | 2 | GO:0004720 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 3.01e-04 | 310 | 109 | 8 | GO:0030246 | |
| GeneOntologyMolecularFunction | peptide binding | 3.57e-04 | 318 | 109 | 8 | GO:0042277 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activator activity involved in apoptotic process | 5.21e-04 | 29 | 109 | 3 | GO:0008656 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 6.52e-04 | 192 | 109 | 6 | GO:0008234 | |
| GeneOntologyMolecularFunction | peptidase activator activity involved in apoptotic process | 6.99e-04 | 32 | 109 | 3 | GO:0016505 | |
| GeneOntologyMolecularFunction | insulin-like growth factor II binding | 8.09e-04 | 8 | 109 | 2 | GO:0031995 | |
| GeneOntologyMolecularFunction | collagen binding | 1.01e-03 | 81 | 109 | 4 | GO:0005518 | |
| GeneOntologyMolecularFunction | fibronectin binding | 1.16e-03 | 38 | 109 | 3 | GO:0001968 | |
| GeneOntologyMolecularFunction | cysteine-type exopeptidase activity | 1.29e-03 | 10 | 109 | 2 | GO:0070004 | |
| GeneOntologyMolecularFunction | monosaccharide binding | 1.83e-03 | 95 | 109 | 4 | GO:0048029 | |
| GeneOntologyMolecularFunction | D-glucose binding | 2.57e-03 | 14 | 109 | 2 | GO:0005536 | |
| GeneOntologyMolecularFunction | calcium ion binding | PRSS3 CUBN F7 CAPN13 THBS3 LOXL2 PCDH11X LTBP2 NOTCH1 NOTCH4 MASP2 | 2.62e-03 | 749 | 109 | 11 | GO:0005509 |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase regulator activity involved in apoptotic process | 3.21e-03 | 54 | 109 | 3 | GO:0043028 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor | 3.37e-03 | 16 | 109 | 2 | GO:0016641 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 3.81e-03 | 17 | 109 | 2 | GO:0042813 | |
| GeneOntologyMolecularFunction | calcium-dependent cysteine-type endopeptidase activity | 3.81e-03 | 17 | 109 | 2 | GO:0004198 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 4.12e-03 | 59 | 109 | 3 | GO:1901505 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 4.75e-03 | 19 | 109 | 2 | GO:0005520 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors | 5.26e-03 | 20 | 109 | 2 | GO:0016638 | |
| GeneOntologyMolecularFunction | oligosaccharide binding | 5.26e-03 | 20 | 109 | 2 | GO:0070492 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 5.42e-03 | 709 | 109 | 10 | GO:0016773 | |
| GeneOntologyMolecularFunction | carbohydrate kinase activity | 5.79e-03 | 21 | 109 | 2 | GO:0019200 | |
| GeneOntologyBiologicalProcess | thyroid hormone generation | 1.92e-07 | 25 | 110 | 5 | GO:0006590 | |
| GeneOntologyBiologicalProcess | thyroid hormone metabolic process | 9.68e-07 | 34 | 110 | 5 | GO:0042403 | |
| GeneOntologyBiologicalProcess | collagen catabolic process | 9.21e-06 | 53 | 110 | 5 | GO:0030574 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 1.01e-05 | 258 | 110 | 9 | GO:0001763 | |
| GeneOntologyBiologicalProcess | anatomical structure maturation | 2.00e-05 | 354 | 110 | 10 | GO:0071695 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 3.92e-05 | 236 | 110 | 8 | GO:0061138 | |
| GeneOntologyBiologicalProcess | branching involved in lymph vessel morphogenesis | 8.43e-05 | 3 | 110 | 2 | GO:0060854 | |
| GeneOntologyBiologicalProcess | connective tissue development | 9.31e-05 | 343 | 110 | 9 | GO:0061448 | |
| GeneOntologyBiologicalProcess | phenol-containing compound metabolic process | 1.14e-04 | 142 | 110 | 6 | GO:0018958 | |
| GeneOntologyBiologicalProcess | developmental maturation | 1.21e-04 | 439 | 110 | 10 | GO:0021700 | |
| GeneOntologyBiologicalProcess | collagen metabolic process | 1.43e-04 | 148 | 110 | 6 | GO:0032963 | |
| GeneOntologyBiologicalProcess | positive regulation of aorta morphogenesis | 1.68e-04 | 4 | 110 | 2 | GO:1903849 | |
| GeneOntologyBiologicalProcess | modified amino acid metabolic process | 1.69e-04 | 218 | 110 | 7 | GO:0006575 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.90e-04 | 377 | 110 | 9 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.93e-04 | 378 | 110 | 9 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.97e-04 | 379 | 110 | 9 | GO:0045229 | |
| GeneOntologyBiologicalProcess | hair cycle phase | 2.42e-04 | 23 | 110 | 3 | GO:0044851 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine oxidation | 2.79e-04 | 5 | 110 | 2 | GO:0018057 | |
| GeneOntologyBiologicalProcess | carbohydrate phosphorylation | 3.12e-04 | 25 | 110 | 3 | GO:0046835 | |
| GeneOntologyBiologicalProcess | cartilage development | 3.28e-04 | 243 | 110 | 7 | GO:0051216 | |
| GeneOntologyBiologicalProcess | regulation of aorta morphogenesis | 4.17e-04 | 6 | 110 | 2 | GO:1903847 | |
| GeneOntologyBiologicalProcess | epidermal cell fate specification | 4.17e-04 | 6 | 110 | 2 | GO:0009957 | |
| GeneOntologyCellularComponent | endolysosome lumen | 1.45e-06 | 5 | 111 | 3 | GO:0036021 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.21e-04 | 530 | 111 | 11 | GO:0062023 | |
| GeneOntologyCellularComponent | lysosomal lumen | 1.77e-04 | 98 | 111 | 5 | GO:0043202 | |
| GeneOntologyCellularComponent | extracellular matrix | PRSS3 F7 LGALS1 NTN4 THBS3 ADAMTS7 LOXL2 LOXL4 LTBP2 CTSB CTSL CTSV | 1.91e-04 | 656 | 111 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | PRSS3 F7 LGALS1 NTN4 THBS3 ADAMTS7 LOXL2 LOXL4 LTBP2 CTSB CTSL CTSV | 1.97e-04 | 658 | 111 | 12 | GO:0030312 |
| GeneOntologyCellularComponent | cell surface | INSR CUBN ITGB8 LGALS1 FZD1 IGF2R ADAMTS7 CD163L1 FSHR PKD1 CTSB CTSK CTSL CTSV NOTCH1 NOTCH4 | 2.54e-04 | 1111 | 111 | 16 | GO:0009986 |
| GeneOntologyCellularComponent | vacuolar lumen | 3.79e-04 | 178 | 111 | 6 | GO:0005775 | |
| GeneOntologyCellularComponent | manchette | 4.33e-04 | 28 | 111 | 3 | GO:0002177 | |
| GeneOntologyCellularComponent | endolysosome | 5.33e-04 | 30 | 111 | 3 | GO:0036019 | |
| GeneOntologyCellularComponent | endosome | FKBP15 AVPR2 PLA2G3 INSR DGKQ CUBN BIRC6 PANK1 IGF2R FSHR CTSB CTSK CTSL CTSV NOTCH1 | 1.29e-03 | 1167 | 111 | 15 | GO:0005768 |
| GeneOntologyCellularComponent | endosome lumen | 1.54e-03 | 43 | 111 | 3 | GO:0031904 | |
| MousePheno | detached acrosome | 2.85e-07 | 44 | 87 | 6 | MP:0009231 | |
| MousePheno | kinked sperm flagellum | 1.23e-06 | 56 | 87 | 6 | MP:0009237 | |
| MousePheno | ectopic manchette | 5.05e-06 | 19 | 87 | 4 | MP:0009377 | |
| MousePheno | abnormal sperm nucleus morphology | 6.44e-06 | 74 | 87 | 6 | MP:0009232 | |
| MousePheno | periodontal ligament necrosis | 3.83e-05 | 2 | 87 | 2 | MP:0030515 | |
| MousePheno | abnormal lymph node medullary sinus morphology | 3.83e-05 | 2 | 87 | 2 | MP:0011222 | |
| MousePheno | dilated lymph node medullary sinus | 3.83e-05 | 2 | 87 | 2 | MP:0011223 | |
| MousePheno | abnormal acrosome morphology | 5.88e-05 | 159 | 87 | 7 | MP:0008898 | |
| MousePheno | abnormal endocrine gland morphology | DMXL2 EPM2A KLK10 KLHL1 PARG INSR SSTR5 PGC TG SLC22A6 LMNA WDHD1 FSHR PKD1 PARL CTSB CTSL CTSV NOTCH1 | 6.21e-05 | 1144 | 87 | 19 | MP:0013560 |
| MousePheno | amyloidosis | 6.32e-05 | 35 | 87 | 4 | MP:0000604 | |
| MousePheno | abnormal amyloid deposition | 6.32e-05 | 35 | 87 | 4 | MP:0021152 | |
| MousePheno | orthokeratosis | 1.23e-04 | 16 | 87 | 3 | MP:0009675 | |
| MousePheno | abnormal manchette morphology | 1.72e-04 | 45 | 87 | 4 | MP:0009376 | |
| MousePheno | abnormal thyroid gland morphology | 2.06e-04 | 87 | 87 | 5 | MP:0000681 | |
| MousePheno | abnormal endometrial gland morphology | 2.46e-04 | 20 | 87 | 3 | MP:0009094 | |
| MousePheno | detached sperm flagellum | 2.86e-04 | 21 | 87 | 3 | MP:0008893 | |
| MousePheno | thymus atrophy | 3.49e-04 | 54 | 87 | 4 | MP:0003644 | |
| MousePheno | heart hemorrhage | 3.75e-04 | 55 | 87 | 4 | MP:0009698 | |
| MousePheno | folliculitis | 3.78e-04 | 5 | 87 | 2 | MP:0000376 | |
| MousePheno | dental pulp necrosis | 3.78e-04 | 5 | 87 | 2 | MP:0013251 | |
| MousePheno | hair follicle outer root sheath hyperplasia | 3.78e-04 | 5 | 87 | 2 | MP:0010688 | |
| MousePheno | enlarged thymus cortex | 3.78e-04 | 5 | 87 | 2 | MP:0013593 | |
| MousePheno | rough coat | 4.29e-04 | 24 | 87 | 3 | MP:0010179 | |
| MousePheno | increased central memory CD4-positive, alpha-beta T cell number | 4.29e-04 | 24 | 87 | 3 | MP:0010841 | |
| MousePheno | premature bone ossification | 5.46e-04 | 26 | 87 | 3 | MP:0003416 | |
| MousePheno | insulitis | 5.46e-04 | 26 | 87 | 3 | MP:0004031 | |
| Domain | THIOL_PROTEASE_CYS | 7.61e-09 | 26 | 110 | 6 | PS00139 | |
| Domain | THIOL_PROTEASE_ASN | 9.73e-09 | 27 | 110 | 6 | PS00640 | |
| Domain | THIOL_PROTEASE_HIS | 9.73e-09 | 27 | 110 | 6 | PS00639 | |
| Domain | TRYPSIN_SER | 2.09e-07 | 106 | 110 | 8 | PS00135 | |
| Domain | TRYPSIN_HIS | 2.25e-07 | 107 | 110 | 8 | PS00134 | |
| Domain | Pept_asp_AS | 2.33e-07 | 10 | 110 | 4 | IPR025661 | |
| Domain | Peptidase_S1A | 3.43e-07 | 113 | 110 | 8 | IPR001314 | |
| Domain | Pept_his_AS | 3.64e-07 | 11 | 110 | 4 | IPR025660 | |
| Domain | TRYPSIN_DOM | 3.93e-07 | 115 | 110 | 8 | PS50240 | |
| Domain | Tryp_SPc | 4.48e-07 | 117 | 110 | 8 | SM00020 | |
| Domain | Pept_cys_AS | 5.70e-07 | 28 | 110 | 5 | IPR000169 | |
| Domain | Trypsin | 5.80e-07 | 121 | 110 | 8 | PF00089 | |
| Domain | Trypsin_dom | 5.80e-07 | 121 | 110 | 8 | IPR001254 | |
| Domain | Peptidase_S1_PA | 6.58e-07 | 123 | 110 | 8 | IPR009003 | |
| Domain | Pept_C1 | 7.82e-07 | 13 | 110 | 4 | SM00645 | |
| Domain | Peptidase_C1A_C | 7.82e-07 | 13 | 110 | 4 | IPR000668 | |
| Domain | Peptidase_C1 | 7.82e-07 | 13 | 110 | 4 | PF00112 | |
| Domain | Peptidase_C1A | 7.82e-07 | 13 | 110 | 4 | IPR013128 | |
| Domain | EGF_Ca-bd_CS | 1.68e-06 | 97 | 110 | 7 | IPR018097 | |
| Domain | EGF_CA | 1.93e-06 | 99 | 110 | 7 | PS01187 | |
| Domain | TRYPSIN_HIS | 2.52e-06 | 103 | 110 | 7 | IPR018114 | |
| Domain | EGF_1 | 2.67e-06 | 255 | 110 | 10 | PS00022 | |
| Domain | EGF-like_CS | 3.29e-06 | 261 | 110 | 10 | IPR013032 | |
| Domain | Growth_fac_rcpt_ | 3.94e-06 | 156 | 110 | 8 | IPR009030 | |
| Domain | Inhibitor_I29 | 6.84e-06 | 7 | 110 | 3 | PF08246 | |
| Domain | Prot_inhib_I29 | 6.84e-06 | 7 | 110 | 3 | IPR013201 | |
| Domain | Inhibitor_I29 | 6.84e-06 | 7 | 110 | 3 | SM00848 | |
| Domain | EGF_CA | 7.78e-06 | 122 | 110 | 7 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 8.66e-06 | 124 | 110 | 7 | IPR001881 | |
| Domain | EGF | 1.05e-05 | 235 | 110 | 9 | SM00181 | |
| Domain | EGF_CA | 1.17e-05 | 86 | 110 | 6 | PF07645 | |
| Domain | EGF_2 | 2.71e-05 | 265 | 110 | 9 | PS01186 | |
| Domain | ASX_HYDROXYL | 2.77e-05 | 100 | 110 | 6 | PS00010 | |
| Domain | Tyr_kinase_rcpt_2_CS | 3.17e-05 | 11 | 110 | 3 | IPR002011 | |
| Domain | M_domain | 3.44e-05 | 2 | 110 | 2 | PF12938 | |
| Domain | GW182_M_dom | 3.44e-05 | 2 | 110 | 2 | IPR026805 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.85e-05 | 106 | 110 | 6 | IPR000152 | |
| Domain | RECEPTOR_TYR_KIN_II | 4.21e-05 | 12 | 110 | 3 | PS00239 | |
| Domain | EGF_3 | 7.58e-05 | 235 | 110 | 8 | PS50026 | |
| Domain | EGF | 1.01e-04 | 126 | 110 | 6 | PF00008 | |
| Domain | Ago_hook | 1.03e-04 | 3 | 110 | 2 | PF10427 | |
| Domain | TNRC6_PABC-bd | 1.03e-04 | 3 | 110 | 2 | IPR032226 | |
| Domain | Argonaute_hook_dom | 1.03e-04 | 3 | 110 | 2 | IPR019486 | |
| Domain | TNRC6-PABC_bdg | 1.03e-04 | 3 | 110 | 2 | PF16608 | |
| Domain | EGF-like_dom | 1.13e-04 | 249 | 110 | 8 | IPR000742 | |
| Domain | TRYPSIN_SER | 1.91e-04 | 90 | 110 | 5 | IPR033116 | |
| Domain | Notch | 2.05e-04 | 4 | 110 | 2 | IPR008297 | |
| Domain | NODP | 2.05e-04 | 4 | 110 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 2.05e-04 | 4 | 110 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 2.05e-04 | 4 | 110 | 2 | IPR010660 | |
| Domain | NOD | 2.05e-04 | 4 | 110 | 2 | PF06816 | |
| Domain | NOD | 2.05e-04 | 4 | 110 | 2 | SM01338 | |
| Domain | NODP | 2.05e-04 | 4 | 110 | 2 | SM01339 | |
| Domain | SRCR | 2.45e-04 | 21 | 110 | 3 | PF00530 | |
| Domain | Lysyl_oxidase | 3.40e-04 | 5 | 110 | 2 | IPR001695 | |
| Domain | Hexokinase_C | 3.40e-04 | 5 | 110 | 2 | IPR022673 | |
| Domain | Hexokinase_N | 3.40e-04 | 5 | 110 | 2 | IPR022672 | |
| Domain | Hexokinase_1 | 3.40e-04 | 5 | 110 | 2 | PF00349 | |
| Domain | LYSYL_OXIDASE | 3.40e-04 | 5 | 110 | 2 | PS00926 | |
| Domain | Hexokinase_2 | 3.40e-04 | 5 | 110 | 2 | PF03727 | |
| Domain | LNR | 3.40e-04 | 5 | 110 | 2 | PS50258 | |
| Domain | HEXOKINASE_2 | 3.40e-04 | 5 | 110 | 2 | PS51748 | |
| Domain | Lysyl_oxidase_CS | 3.40e-04 | 5 | 110 | 2 | IPR019828 | |
| Domain | Hexokinase_BS | 3.40e-04 | 5 | 110 | 2 | IPR019807 | |
| Domain | HEXOKINASE_1 | 3.40e-04 | 5 | 110 | 2 | PS00378 | |
| Domain | Lysyl_oxidase | 3.40e-04 | 5 | 110 | 2 | PF01186 | |
| Domain | SR | 4.16e-04 | 25 | 110 | 3 | SM00202 | |
| Domain | - | 4.16e-04 | 25 | 110 | 3 | 3.10.250.10 | |
| Domain | EGF_extracell | 4.31e-04 | 60 | 110 | 4 | IPR013111 | |
| Domain | EGF_2 | 4.31e-04 | 60 | 110 | 4 | PF07974 | |
| Domain | SRCR_1 | 4.68e-04 | 26 | 110 | 3 | PS00420 | |
| Domain | SRCR_2 | 4.68e-04 | 26 | 110 | 3 | PS50287 | |
| Domain | SRCR-like_dom | 4.68e-04 | 26 | 110 | 3 | IPR017448 | |
| Domain | Hexokinase | 5.08e-04 | 6 | 110 | 2 | IPR001312 | |
| Domain | SRCR | 5.25e-04 | 27 | 110 | 3 | IPR001190 | |
| Domain | Notch_dom | 7.08e-04 | 7 | 110 | 2 | IPR000800 | |
| Domain | Notch | 7.08e-04 | 7 | 110 | 2 | PF00066 | |
| Domain | NL | 7.08e-04 | 7 | 110 | 2 | SM00004 | |
| Domain | TyrKc | 1.82e-03 | 88 | 110 | 4 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 1.82e-03 | 88 | 110 | 4 | IPR020635 | |
| Domain | FAD-dep_OxRdtase | 2.18e-03 | 12 | 110 | 2 | IPR006076 | |
| Domain | DAO | 2.18e-03 | 12 | 110 | 2 | PF01266 | |
| Domain | Calpain_domain_III | 2.57e-03 | 13 | 110 | 2 | IPR022682 | |
| Domain | Calpain_III | 2.57e-03 | 13 | 110 | 2 | PF01067 | |
| Domain | PROTEIN_KINASE_TYR | 2.59e-03 | 97 | 110 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 2.59e-03 | 97 | 110 | 4 | IPR008266 | |
| Domain | Calpain_cysteine_protease | 2.99e-03 | 14 | 110 | 2 | IPR022684 | |
| Domain | CysPc | 3.43e-03 | 15 | 110 | 2 | SM00230 | |
| Domain | Peptidase_C2_calpain_cat | 3.43e-03 | 15 | 110 | 2 | IPR001300 | |
| Domain | Peptidase_C2 | 3.43e-03 | 15 | 110 | 2 | PF00648 | |
| Domain | CALPAIN_CAT | 3.43e-03 | 15 | 110 | 2 | PS50203 | |
| Domain | LRRNT | 3.76e-03 | 53 | 110 | 3 | PF01462 | |
| Domain | Gal_Oxase/kelch_b-propeller | 5.09e-03 | 59 | 110 | 3 | IPR011043 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | PRSS3 ITGB8 CAPN13 LOXL2 CAPN7 LOXL4 LTBP2 CTSB CTSK CTSL CTSV | 1.64e-07 | 258 | 78 | 11 | MM14572 |
| Pathway | REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR | 5.97e-07 | 13 | 78 | 4 | MM14659 | |
| Pathway | REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR | 5.97e-07 | 13 | 78 | 4 | M593 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | ITGB8 CAPN13 NTN4 LOXL2 CAPN7 LOXL4 LTBP2 CTSB CTSK CTSL CTSV | 7.40e-07 | 300 | 78 | 11 | M610 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.09e-06 | 114 | 78 | 7 | MM14571 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 7.94e-06 | 50 | 78 | 5 | MM14796 | |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_KERATINOCYTES | 8.95e-06 | 8 | 78 | 3 | M27796 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.13e-05 | 61 | 78 | 5 | M27103 | |
| Pathway | REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES | 5.55e-05 | 38 | 78 | 4 | MM14611 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 6.16e-05 | 39 | 78 | 4 | MM14601 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 6.19e-05 | 76 | 78 | 5 | MM14573 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 9.95e-05 | 44 | 78 | 4 | M26969 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.23e-04 | 140 | 78 | 6 | M587 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.39e-04 | 90 | 78 | 5 | M631 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.07e-04 | 53 | 78 | 4 | MM14566 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 2.46e-04 | 381 | 78 | 9 | M48063 | |
| Pathway | REACTOME_HDL_CLEARANCE | 2.99e-04 | 5 | 78 | 2 | M27844 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 2.99e-04 | 5 | 78 | 2 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 2.99e-04 | 5 | 78 | 2 | MM14733 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_FIMA_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS | 4.47e-04 | 6 | 78 | 2 | M47654 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 4.47e-04 | 6 | 78 | 2 | M27068 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 4.53e-04 | 116 | 78 | 5 | MM14855 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 5.40e-04 | 68 | 78 | 4 | M27303 | |
| Pathway | KEGG_LYSOSOME | 5.49e-04 | 121 | 78 | 5 | M11266 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 6.23e-04 | 7 | 78 | 2 | MM14734 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 6.23e-04 | 7 | 78 | 2 | M46421 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 6.60e-04 | 126 | 78 | 5 | M705 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 1.06e-03 | 9 | 78 | 2 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 1.06e-03 | 9 | 78 | 2 | M46436 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 1.32e-03 | 10 | 78 | 2 | M48013 | |
| Pathway | REACTOME_UPTAKE_OF_DIETARY_COBALAMINS_INTO_ENTEROCYTES | 1.32e-03 | 10 | 78 | 2 | M45024 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 1.61e-03 | 11 | 78 | 2 | M47865 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 1.61e-03 | 11 | 78 | 2 | M525 | |
| Pathway | REACTOME_SIGNALING_BY_ALK_IN_CANCER | 1.74e-03 | 93 | 78 | 4 | M42521 | |
| Pathway | BIOCARTA_HES_PATHWAY | 1.92e-03 | 12 | 78 | 2 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 1.92e-03 | 12 | 78 | 2 | M22042 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 1.92e-03 | 12 | 78 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.92e-03 | 12 | 78 | 2 | M47533 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 2.19e-03 | 99 | 78 | 4 | M27474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 2.27e-03 | 13 | 78 | 2 | M47423 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 2.27e-03 | 13 | 78 | 2 | M47534 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 2.27e-03 | 13 | 78 | 2 | M46434 | |
| Pubmed | 3.46e-13 | 5 | 114 | 5 | 12782676 | ||
| Pubmed | Cathepsin protease activity modulates amyloid load in extracerebral amyloidosis. | 1.09e-10 | 4 | 114 | 4 | 17068745 | |
| Pubmed | 1.09e-10 | 4 | 114 | 4 | 16939398 | ||
| Pubmed | Cathepsin V, but not cathepsins L, B and K, may release angiostatin-like fragments from plasminogen. | 5.46e-10 | 5 | 114 | 4 | 18163891 | |
| Pubmed | 5.46e-10 | 5 | 114 | 4 | 33786919 | ||
| Pubmed | 7.59e-09 | 8 | 114 | 4 | 28835281 | ||
| Pubmed | Asparagine endopeptidase controls anti-influenza virus immune responses through TLR7 activation. | 7.59e-09 | 8 | 114 | 4 | 22916010 | |
| Pubmed | 2.26e-08 | 10 | 114 | 4 | 20541250 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 23233448 | ||
| Pubmed | Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. | 3.43e-08 | 3 | 114 | 3 | 15831716 | |
| Pubmed | Proteolytic cleavage of the disease-related lysosomal membrane glycoprotein CLN7. | 3.43e-08 | 3 | 114 | 3 | 22668694 | |
| Pubmed | Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption. | 3.43e-08 | 3 | 114 | 3 | 19028686 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 17889653 | ||
| Pubmed | Proteomic analysis of cathepsin B- and L-deficient mouse brain lysosomes. | 3.43e-08 | 3 | 114 | 3 | 17765022 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 16731916 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 30931961 | ||
| Pubmed | Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells. | 3.43e-08 | 3 | 114 | 3 | 11986312 | |
| Pubmed | Proteolytic disassembly is a critical determinant for reovirus oncolysis. | 3.43e-08 | 3 | 114 | 3 | 17519890 | |
| Pubmed | Expression of cysteine proteases in extraembryonic tissues during mouse embryogenesis. | 3.43e-08 | 3 | 114 | 3 | 10600178 | |
| Pubmed | Neuronal loss and brain atrophy in mice lacking cathepsins B and L. | 3.43e-08 | 3 | 114 | 3 | 12048238 | |
| Pubmed | Up-regulation of cathepsin B and cathepsin L activities in scrapie-infected mouse Neuro2a cells. | 3.43e-08 | 3 | 114 | 3 | 12867662 | |
| Pubmed | Cathepsin B & L are not required for ebola virus replication. | 3.43e-08 | 3 | 114 | 3 | 23236527 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 22126332 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 36038449 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 24319737 | ||
| Pubmed | Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis. | 1.37e-07 | 4 | 114 | 3 | 26075905 | |
| Pubmed | Identification of pathogenic T cell epitopes near cathepsin cleavage sites in thyroglobulin. | 1.37e-07 | 4 | 114 | 3 | 23315080 | |
| Pubmed | Expression of cathepsin proteinases by mouse trophoblast in vivo and in vitro. | 1.37e-07 | 4 | 114 | 3 | 10633857 | |
| Pubmed | Spatially and temporally defined lysosomal leakage facilitates mitotic chromosome segregation. | 1.37e-07 | 4 | 114 | 3 | 31932607 | |
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 21251246 | ||
| Pubmed | Cysteine cathepsins are essential in lysosomal degradation of α-synuclein. | 1.37e-07 | 4 | 114 | 3 | 26170293 | |
| Pubmed | A new pathway that regulates 53BP1 stability implicates cathepsin L and vitamin D in DNA repair. | 1.37e-07 | 4 | 114 | 3 | 21750527 | |
| Pubmed | Genetic and pharmacologic alteration of cathepsin expression influences reovirus pathogenesis. | 1.37e-07 | 4 | 114 | 3 | 19640986 | |
| Pubmed | Roles for cathepsins S, L, and B in insulitis and diabetes in the NOD mouse. | 1.37e-07 | 4 | 114 | 3 | 19664906 | |
| Pubmed | Unconventional Trafficking of Mammalian Phospholipase D3 to Lysosomes. | 1.37e-07 | 4 | 114 | 3 | 29386126 | |
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 26693174 | ||
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 16314482 | ||
| Pubmed | [The lysosomal cathepsins B, L and D in development of murine experimental leukemias]. | 1.37e-07 | 4 | 114 | 3 | 20017393 | |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 1.37e-07 | 4 | 114 | 3 | 19091768 | |
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 33758261 | ||
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 10395917 | ||
| Pubmed | Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. | 3.41e-07 | 5 | 114 | 3 | 16481467 | |
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 12186844 | ||
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 15308097 | ||
| Pubmed | Asparagine endopeptidase is required for normal kidney physiology and homeostasis. | 3.41e-07 | 5 | 114 | 3 | 21292981 | |
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 23468951 | ||
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 27997605 | ||
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 3.41e-07 | 5 | 114 | 3 | 17855024 | |
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 15905550 | ||
| Pubmed | 6.81e-07 | 6 | 114 | 3 | 24145449 | ||
| Pubmed | 6.81e-07 | 6 | 114 | 3 | 18591414 | ||
| Pubmed | Mouse cathepsin M, a placenta-specific lysosomal cysteine protease related to cathepsins L and P. | 6.81e-07 | 6 | 114 | 3 | 10760593 | |
| Pubmed | Biogenesis and proteolytic processing of lysosomal DNase II. | 6.81e-07 | 6 | 114 | 3 | 23516607 | |
| Pubmed | 6.81e-07 | 6 | 114 | 3 | 20080943 | ||
| Pubmed | 1.19e-06 | 7 | 114 | 3 | 12775715 | ||
| Pubmed | 1.19e-06 | 7 | 114 | 3 | 24388751 | ||
| Pubmed | A role for cathepsin E in the processing of mast-cell carboxypeptidase A. | 1.19e-06 | 7 | 114 | 3 | 15860733 | |
| Pubmed | 1.19e-06 | 7 | 114 | 3 | 11830565 | ||
| Pubmed | 1.19e-06 | 7 | 114 | 3 | 27477282 | ||
| Pubmed | 1.89e-06 | 175 | 114 | 7 | 28071719 | ||
| Pubmed | Serum Amyloid A-Mediated Inflammasome Activation of Microglial Cells in Cerebral Ischemia. | 1.90e-06 | 8 | 114 | 3 | 31611307 | |
| Pubmed | 1.90e-06 | 8 | 114 | 3 | 9310336 | ||
| Pubmed | The SPOT technique as a tool for studying protein tyrosine phosphatase substrate specificities. | 2.84e-06 | 9 | 114 | 3 | 12237455 | |
| Pubmed | Induced expression of cathepsins and cystatin C in a murine model of demyelination. | 2.84e-06 | 9 | 114 | 3 | 17086443 | |
| Pubmed | Cleavage of nidogen-1 by cathepsin S impairs its binding to basement membrane partners. | 2.84e-06 | 9 | 114 | 3 | 22952693 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CRYBG2 SLC37A3 DGKQ PIGG TNRC6C BIRC6 CCDC142 FZD1 IGF2R ADAMTS7 PKD1 PDIA5 LTK TIMM22 NOTCH1 | 3.42e-06 | 1105 | 114 | 15 | 35748872 |
| Pubmed | NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. | 4.05e-06 | 10 | 114 | 3 | 20428172 | |
| Pubmed | 4.05e-06 | 10 | 114 | 3 | 28087651 | ||
| Pubmed | 5.55e-06 | 11 | 114 | 3 | 26682926 | ||
| Pubmed | 5.95e-06 | 36 | 114 | 4 | 33737325 | ||
| Pubmed | 7.38e-06 | 12 | 114 | 3 | 9096102 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 9.76e-06 | 86 | 114 | 5 | 28327460 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 19801522 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 36735789 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 35931115 | ||
| Pubmed | Cathepsin L promotes Vascular Intimal Hyperplasia after Arterial Injury. | 1.07e-05 | 2 | 114 | 2 | 28332696 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 24108784 | ||
| Pubmed | Differential patterns of NOTCH1-4 receptor expression are markers of glioma cell differentiation. | 1.07e-05 | 2 | 114 | 2 | 24305720 | |
| Pubmed | Impaired turnover of autophagolysosomes in cathepsin L deficiency. | 1.07e-05 | 2 | 114 | 2 | 20536383 | |
| Pubmed | Nuclear cysteine cathepsin variants in thyroid carcinoma cells. | 1.07e-05 | 2 | 114 | 2 | 20536394 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 12496471 | ||
| Pubmed | Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice. | 1.07e-05 | 2 | 114 | 2 | 16636100 | |
| Pubmed | Cathepsin L Regulates Metabolic Networks Controlling Rapid Cell Growth and Proliferation. | 1.07e-05 | 2 | 114 | 2 | 31010818 | |
| Pubmed | Promiscuous processing of human alphabeta-protryptases by cathepsins L, B, and C. | 1.07e-05 | 2 | 114 | 2 | 21562164 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 15816632 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 25991043 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 20837372 | ||
| Pubmed | Cystatin B, cathepsin L and D related to surrogate markers for cardiovascular disease in children. | 1.07e-05 | 2 | 114 | 2 | 29149174 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 23389453 | ||
| Pubmed | A variant of pulmonary alveolar microlithiasis in nackt mice. | 1.07e-05 | 2 | 114 | 2 | 12014504 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 11112321 | ||
| Pubmed | Mice that express enzymatically inactive cathepsin L exhibit abnormal spermatogenesis. | 1.07e-05 | 2 | 114 | 2 | 12533435 | |
| Pubmed | Thymosin beta4 induces angiogenesis through Notch signaling in endothelial cells. | 1.07e-05 | 2 | 114 | 2 | 23749167 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 27902765 | ||
| Pubmed | Cathepsin L was involved in vascular aging by mediating phenotypic transformation of vascular cells. | 1.07e-05 | 2 | 114 | 2 | 36206719 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 3689328 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 17671649 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 16913838 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 21972973 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 16705169 | ||
| GeneFamily | Cathepsins | 4.22e-07 | 15 | 78 | 4 | 470 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 2.60e-05 | 40 | 78 | 4 | 321 | |
| GeneFamily | Proteases, serine | 1.57e-04 | 63 | 78 | 4 | 738 | |
| GeneFamily | C2 domain containing|Calpains | 1.86e-03 | 15 | 78 | 2 | 975 | |
| Coexpression | NABA_ECM_REGULATORS | 8.65e-08 | 238 | 113 | 10 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 1.01e-07 | 242 | 113 | 10 | MM17062 | |
| Coexpression | HENDRICKS_SMARCA4_TARGETS_UP | 3.64e-06 | 54 | 113 | 5 | M15057 | |
| Coexpression | NABA_MATRISOME_HYPERPLASTIC_PANCREATIC_ISLETS | 4.55e-06 | 26 | 113 | 4 | MM17051 | |
| Coexpression | NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 4.21e-05 | 294 | 113 | 8 | M41112 | |
| ToppCell | mLN-(2)_B_cell-(20)_B_cell_IgA_Plasma|mLN / shred on region, Cell_type, and subtype | 7.68e-07 | 197 | 114 | 7 | a39b384ee9824a08c3b544a9c3c7f0f95f08d6a7 | |
| ToppCell | mLN-B_cell-B_cell_IgA_Plasma|mLN / Region, Cell class and subclass | 7.68e-07 | 197 | 114 | 7 | 20822fce311326765b71337ce501ba44ea14f58f | |
| ToppCell | 3'-GW_trimst-2|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.95e-07 | 198 | 114 | 7 | cf9861bc14737f2dc72e50222159e0180a6d3e5c | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.12e-06 | 164 | 114 | 6 | 95b800c78871354c859abaa832d778786ef7bcc0 | |
| ToppCell | severe-Myeloid-pDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.42e-06 | 166 | 114 | 6 | ae38850fde549b8dd6fb12f0ef80b428ade50485 | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 5.07e-06 | 170 | 114 | 6 | fbb7019c6fba87326702b51f6819ea1af5f3a9b7 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.24e-06 | 171 | 114 | 6 | b520d4d5620cac08315e4cbb7e796c5e9e233060 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class | 5.79e-06 | 174 | 114 | 6 | 4c64ff5666812fb4efa440ba4faeca51d916d68e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_MT-positive-Alveolar_macrophage_MT-positive_L.1.0.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.99e-06 | 175 | 114 | 6 | b227d4499274fb63b193d34de7f2d812e283e79d | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_MT-positive|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.99e-06 | 175 | 114 | 6 | 308ee4ef7b9ecea68efca011ef91aed0f1be0eca | |
| ToppCell | B_cells-pDCs|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 6.18e-06 | 176 | 114 | 6 | ce757de9e09a225f3f96433f103f43619b0e0dda | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.18e-06 | 176 | 114 | 6 | 270d7908dbd84028958d257f94941dc685e20255 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 6.39e-06 | 177 | 114 | 6 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | Healthy/Control-pDC|World / Disease group and Cell class | 7.49e-06 | 182 | 114 | 6 | 97e0eee10905f2cf2bebb09e474629fc224f4397 | |
| ToppCell | BAL-Control-Myeloid-Macrophage|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.73e-06 | 183 | 114 | 6 | 8e9d45c96b44558158e3d59613f64a73d5390c19 | |
| ToppCell | BAL-Control-Myeloid-Macrophage-transitional_Macro-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.73e-06 | 183 | 114 | 6 | 0408d991ddb639594b45d5cb2432dd29289167b1 | |
| ToppCell | BAL-Control-Myeloid-Macrophage-transitional_Macro|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.73e-06 | 183 | 114 | 6 | 79f05b8a967124d831b0baef137e30659f5917a7 | |
| ToppCell | BAL-Control-Myeloid-Macrophage-transitional_Macro-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.97e-06 | 184 | 114 | 6 | 92202e1cd0bba1ce4b061ebcb8a2af5bb590542a | |
| ToppCell | normal_Lung-Endothelial_cells-Tumor_ECs|normal_Lung / Location, Cell class and cell subclass | 7.97e-06 | 184 | 114 | 6 | 7ee98acda030366ac6cf3890a6d93fd0426712ed | |
| ToppCell | BAL-Control-Myeloid-Macrophage|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.97e-06 | 184 | 114 | 6 | 7331535d469453a5264dcb0270a97f63d3b55201 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.97e-06 | 184 | 114 | 6 | 8fa30789c9d583188667cf375d2218e392dd40bc | |
| ToppCell | BAL-Control-Myeloid-Macrophage-transitional_Macro|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.97e-06 | 184 | 114 | 6 | 337e38a6b2b6770cc992d88b006829f194841b10 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.22e-06 | 185 | 114 | 6 | f3fbc3096f85397a959cee17c3c4fcf2d511f3d5 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.22e-06 | 185 | 114 | 6 | afbb88325e4a81c15ac1d0a004e3e1f4ba2ee87b | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.22e-06 | 185 | 114 | 6 | 4bee178ede12f56ba5f5bec44a03dc2a62c50137 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.74e-06 | 187 | 114 | 6 | f0c6e53035b00772377c4d5f761b4d11026b911a | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.74e-06 | 187 | 114 | 6 | f20e7a1751694390f535ffb27b97e887220f8695 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.01e-06 | 188 | 114 | 6 | e35104ca327c2d9eb6ffed658051f62f855a0a0e | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 9.01e-06 | 188 | 114 | 6 | 409a7b69d02e87084ca955e3fe6c77230dee8861 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Airway_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.29e-06 | 189 | 114 | 6 | 4f9608b84d135268a17455661870c46ae8554a24 | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 9.86e-06 | 191 | 114 | 6 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | Control-pDC|Control / Disease condition and Cell class | 9.86e-06 | 191 | 114 | 6 | 543e1437a52d04436862dd1c27b4fae95c44fcc8 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.86e-06 | 191 | 114 | 6 | 5c0c44612b4cdbf89c0f1f219416374a7541f610 | |
| ToppCell | Control-pDC-|Control / Disease condition and Cell class | 9.86e-06 | 191 | 114 | 6 | 1d7b0fae4d114d6db933c18b4eb2066ffa61356d | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.86e-06 | 191 | 114 | 6 | fbd8d337b4444fba8527a614e4a8bfb516ce0f66 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.02e-05 | 192 | 114 | 6 | 103496f428f59683ac3ae6147682c07c30663724 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 1.05e-05 | 193 | 114 | 6 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.11e-05 | 195 | 114 | 6 | 10fa47bdcf6c9784ea930b75a5861e139421feed | |
| ToppCell | facs-Bladder-nan-18m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 195 | 114 | 6 | 3e4f9ecfaa756386d816a26313b7229ec092d4e6 | |
| ToppCell | Control-Myeloid-Macrophage|Control / Disease state, Lineage and Cell class | 1.14e-05 | 196 | 114 | 6 | e2c2a30fa3ee3034fbde5335be169e880dde622d | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.14e-05 | 196 | 114 | 6 | 9d7b631f24a19a7dc7a28f28525d4019fc8fcf8a | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 197 | 114 | 6 | ad4a3b5da2190be9495382a2952991e1de9f190d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.18e-05 | 197 | 114 | 6 | 1ded28732ea5d1f9ebca0b136575103540600ff1 | |
| ToppCell | moderate-Epithelial-Squamous|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.18e-05 | 197 | 114 | 6 | ab3c90a5b643b45d0b83939c6304b11f567c5d78 | |
| ToppCell | IPF-Myeloid-Macrophage|IPF / Disease state, Lineage and Cell class | 1.18e-05 | 197 | 114 | 6 | a2ffb33c7cad6be43cbb8ed9a91338923cc07db4 | |
| ToppCell | myeloid-Monocyte|myeloid / Lineage, cell class and subclass | 1.18e-05 | 197 | 114 | 6 | 6acf059cee6ba6bdeacc089b090d72336790972a | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 197 | 114 | 6 | cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-05 | 198 | 114 | 6 | ce59ee3d970397eb62d6387699c6c6cd65457898 | |
| ToppCell | PBMC-Mild-cDC_0|Mild / Compartment, Disease Groups and Clusters | 1.21e-05 | 198 | 114 | 6 | fb873b7636bb1c7b119dd5b23d7a20f518e6c6da | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-05 | 198 | 114 | 6 | 75d104eead681f6bf47c4dd24913cc768c9a1717 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 198 | 114 | 6 | 0cd930e374c2c48d1991b51c025f9801b22ecee7 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 198 | 114 | 6 | e0df6d6ff2a9c41d813f84a2a5ee7cb5f6fc3e30 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-05 | 199 | 114 | 6 | edba1833ef5c4ca122d7c32f97670314e005f93b | |
| ToppCell | COPD-Myeloid-Macrophage|COPD / Disease state, Lineage and Cell class | 1.25e-05 | 199 | 114 | 6 | 4b9c53fb4f44190d2f6ad4d52b13be01ebe4955e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-05 | 199 | 114 | 6 | e78f661b40da34768469549b6e755d330be6bbd8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.25e-05 | 199 | 114 | 6 | 463ba77dc4c85eebb343f29a42c7ac889b0497c9 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 1.28e-05 | 200 | 114 | 6 | eabb7d4aa92ace7d970bcd3fae2c7cb5400a43b4 | |
| ToppCell | COVID-19-Myeloid|COVID-19 / Condition, Lineage and Cell class | 1.28e-05 | 200 | 114 | 6 | 4c9e936b5e100c1a3ef10ea262febccf8226df9f | |
| ToppCell | distal-Hematologic-EREG+_Dendritic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.28e-05 | 200 | 114 | 6 | 7809c74a2e52768854b66a135522138281bc4449 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.83e-05 | 138 | 114 | 5 | 611fe0fb284e12678f9c47a0bdbfc367a93c52b3 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.59e-05 | 145 | 114 | 5 | 47a3bb973a508d3097213a2d86ad1ce697af9bae | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 157 | 114 | 5 | 5d08ff0ba9d3df9cc30f13cab2d2b395ea6f3446 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.25e-05 | 157 | 114 | 5 | a93866f051472506f1468f379c0d5313e02c9731 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 157 | 114 | 5 | ad9c9b7dfeee3ae46e7e593c51a0407df12195b4 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.60e-05 | 81 | 114 | 4 | 1a22222f2b4ab30f7aa31820029c267a0f2190ec | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_PENK|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.27e-05 | 163 | 114 | 5 | 551b3788bcf494c6121e64ce5af72266de12a06b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.64e-05 | 165 | 114 | 5 | 4f83ac71efc57be3668d8db1e62bad05dc6a5e2b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.64e-05 | 165 | 114 | 5 | cd8de98af8a1a8a6c81d71fae807cc07f319f4c9 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.83e-05 | 166 | 114 | 5 | 7a45785a40b7425f97be67bab1c5ceb69b2bd85a | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.83e-05 | 166 | 114 | 5 | bbd382812f8a84a5d99888de2d7cca3a8b5e4695 | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.03e-05 | 167 | 114 | 5 | 650de8cd5df070639b8aa292aacead739cfdb02c | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Macrophage|GI_small-bowel / Manually curated celltypes from each tissue | 7.23e-05 | 168 | 114 | 5 | d5b746d6083c2c8155a0ea345ea368bf6617d5ca | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.43e-05 | 169 | 114 | 5 | 7cb1b87be66a22fe5731bb1b55bc515920fe3e8b | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 7.64e-05 | 170 | 114 | 5 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-mLTo|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.64e-05 | 170 | 114 | 5 | 7653f1205d4e62abe7e31b1d76f9bbd665e45667 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.86e-05 | 171 | 114 | 5 | 2b8dbc6fcd829d06f43b875db2bf81f8374428fa | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.53e-05 | 174 | 114 | 5 | b4f3f5334803e5903bc496decf923f2e44f7fa3c | |
| ToppCell | 3'_v3-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue | 9.00e-05 | 176 | 114 | 5 | b9da3deaf62622d47eb30b6be7548253eee95597 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.00e-05 | 176 | 114 | 5 | 460cb302c5b3d609c65b924e1d4e8ea057a68485 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.00e-05 | 176 | 114 | 5 | b0b87eebcf5c994386b39ca607e17f10e9d9de74 | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.24e-05 | 177 | 114 | 5 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.24e-05 | 177 | 114 | 5 | 4553ee8cd9c24db6511b09fe49ed11a89e7cde9e | |
| ToppCell | Healthy/Control-pDC|Healthy/Control / Disease group and Cell class | 9.49e-05 | 178 | 114 | 5 | 072b346c6bbd63f00efaceda486400a669b3ec48 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.49e-05 | 178 | 114 | 5 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.49e-05 | 178 | 114 | 5 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.59e-05 | 93 | 114 | 4 | 6d91b52147fb68461b39223e52026f2a02dcda7f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.59e-05 | 93 | 114 | 4 | d6409351d89f6289411bac4aff65322e91212e57 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.59e-05 | 93 | 114 | 4 | d736a59d48fa0dc41afef67f1a1507105558e47c | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Macrophage|lymph-node_spleen / Manually curated celltypes from each tissue | 9.75e-05 | 179 | 114 | 5 | b4430f633711cecf793e8e76e766a66ff1eff473 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 1.00e-04 | 180 | 114 | 5 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.00e-04 | 180 | 114 | 5 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 1.00e-04 | 180 | 114 | 5 | 4eea8366cdb82c356325ce88f09ad8b302c17a07 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-04 | 181 | 114 | 5 | c35ca98c474e31917e0a53c092397e0d8d18b37c | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-04 | 181 | 114 | 5 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 181 | 114 | 5 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | tumor_Lung-Myeloid_cells-pDCs|tumor_Lung / Location, Cell class and cell subclass | 1.03e-04 | 181 | 114 | 5 | c864ffeb9234b8c29754afc91c85a972889617f4 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-04 | 182 | 114 | 5 | 4234d0cc57b5266a5e03133c75c7918abe48465e | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.05e-04 | 182 | 114 | 5 | bb7de0c93d8f59f13c990e425139b9348ca8027e | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular-Chondrocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.05e-04 | 182 | 114 | 5 | 507f095af4dff60f2c2b64d750477154084c3595 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.05e-04 | 182 | 114 | 5 | 88bd17c07bd8443a0ede4e9dc7bc9d1230b42211 | |
| Computational | Genes in the cancer module 107. | 1.10e-04 | 79 | 65 | 5 | MODULE_107 | |
| Computational | Genes in the cancer module 172. | 2.77e-04 | 96 | 65 | 5 | MODULE_172 | |
| Drug | carbohydrazide | 3.68e-08 | 20 | 111 | 5 | CID000073948 | |
| Drug | Leupeptin hydrochloride | 1.10e-07 | 276 | 111 | 11 | CID000003910 | |
| Drug | benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide | 4.50e-07 | 4 | 111 | 3 | ctd:C021159 | |
| Drug | relacatib | 1.12e-06 | 5 | 111 | 3 | CID006918602 | |
| Drug | AC1NRA23 | 1.53e-06 | 73 | 111 | 6 | CID005287657 | |
| Drug | NSC272671 | 2.24e-06 | 174 | 111 | 8 | CID000004742 | |
| Drug | diisopropylfluorophosphate | 3.95e-06 | 321 | 111 | 10 | CID000005936 | |
| Drug | Spiramycin [8025-81-8]; Up 200; 4.8uM; PC3; HT_HG-U133A | 6.05e-06 | 199 | 111 | 8 | 3762_UP | |
| Drug | thallium | 6.25e-06 | 25 | 111 | 4 | CID000105005 | |
| Drug | cimaterol | 1.16e-05 | 29 | 111 | 4 | CID000002755 | |
| Drug | AC1NBIRU | 1.30e-05 | 62 | 111 | 5 | CID004468718 | |
| Drug | E 64 | 1.42e-05 | 161 | 111 | 7 | CID000123985 | |
| Drug | E64A | 1.52e-05 | 31 | 111 | 4 | CID000173548 | |
| Drug | C01631 | 1.52e-05 | 31 | 111 | 4 | CID000439539 | |
| Drug | desmedipham | 1.52e-05 | 31 | 111 | 4 | CID000024743 | |
| Drug | 3-Amino-5-Phenylpentane | 2.36e-05 | 2 | 111 | 2 | DB02869 | |
| Drug | AC1L2O2K | 2.36e-05 | 2 | 111 | 2 | CID000125141 | |
| Drug | AC1LAR7G | 4.71e-05 | 41 | 111 | 4 | CID000493598 | |
| Drug | Bana | 5.19e-05 | 42 | 111 | 4 | CID000009365 | |
| Drug | quinoline-8-carboxamide | 7.04e-05 | 3 | 111 | 2 | CID000150664 | |
| Drug | AC1L2T7Q | 7.04e-05 | 3 | 111 | 2 | CID000128119 | |
| Drug | Zpambn | 7.04e-05 | 3 | 111 | 2 | CID000192229 | |
| Drug | L-2-amino-6-oxopimelate | 7.30e-05 | 17 | 111 | 3 | CID000194695 | |
| Drug | anthranilic acid | 7.54e-05 | 89 | 111 | 5 | CID000000227 | |
| Drug | PC-PI | 8.72e-05 | 18 | 111 | 3 | CID000007693 | |
| Disease | otitis media (biomarker_via_orthology) | 3.48e-07 | 17 | 105 | 4 | DOID:10754 (biomarker_via_orthology) | |
| Disease | hepatocellular carcinoma (implicated_via_orthology) | 2.84e-05 | 49 | 105 | 4 | DOID:684 (implicated_via_orthology) | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 1.34e-04 | 28 | 105 | 3 | DOID:4194 (implicated_via_orthology) | |
| Disease | Glioblastoma | 1.85e-04 | 79 | 105 | 4 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 2.35e-04 | 84 | 105 | 4 | C0334588 | |
| Disease | Visual Impairment | 2.60e-04 | 7 | 105 | 2 | C3665347 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 3.73e-04 | 171 | 105 | 5 | DOID:9352 (is_implicated_in) | |
| Disease | hemangiopericytoma (is_marker_for) | 4.44e-04 | 9 | 105 | 2 | DOID:264 (is_marker_for) | |
| Disease | Glioblastoma Multiforme | 6.77e-04 | 111 | 105 | 4 | C1621958 | |
| Disease | stenosing tenosynovitis | 8.09e-04 | 12 | 105 | 2 | EFO_0010822 | |
| Disease | intracranial aneurysm (biomarker_via_orthology) | 9.54e-04 | 13 | 105 | 2 | DOID:10941 (biomarker_via_orthology) | |
| Disease | Connective Tissue Diseases | 9.54e-04 | 13 | 105 | 2 | C0009782 | |
| Disease | intracranial aneurysm (is_marker_for) | 1.11e-03 | 14 | 105 | 2 | DOID:10941 (is_marker_for) | |
| Disease | Proteinuria | 1.28e-03 | 15 | 105 | 2 | HP_0000093 | |
| Disease | type 2 diabetes mellitus (is_marker_for) | 1.44e-03 | 136 | 105 | 4 | DOID:9352 (is_marker_for) | |
| Disease | Monogenic diabetes | 1.46e-03 | 16 | 105 | 2 | C3888631 | |
| Disease | Neoplastic Cell Transformation | 1.56e-03 | 139 | 105 | 4 | C0007621 | |
| Disease | breast carcinoma (is_marker_for) | 1.70e-03 | 66 | 105 | 3 | DOID:3459 (is_marker_for) | |
| Disease | Sclerocystic Ovaries | 1.78e-03 | 144 | 105 | 4 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 1.78e-03 | 144 | 105 | 4 | C0032460 | |
| Disease | Congenital hernia of foramen of Morgagni | 2.06e-03 | 19 | 105 | 2 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 2.06e-03 | 19 | 105 | 2 | C0265700 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 2.43e-03 | 157 | 105 | 4 | DOID:14330 (implicated_via_orthology) | |
| Disease | Congenital diaphragmatic hernia | 2.52e-03 | 21 | 105 | 2 | C0235833 | |
| Disease | Lewy Body Disease | 2.77e-03 | 22 | 105 | 2 | C0752347 | |
| Disease | tooth agenesis | 2.77e-03 | 22 | 105 | 2 | EFO_0005410 | |
| Disease | age of onset of asthma | 2.85e-03 | 79 | 105 | 3 | OBA_2001001 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.95e-03 | 80 | 105 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | Carcinoma, Pancreatic Ductal | 3.29e-03 | 24 | 105 | 2 | C0887833 | |
| Disease | nephrotic syndrome (biomarker_via_orthology) | 3.29e-03 | 24 | 105 | 2 | DOID:1184 (biomarker_via_orthology) | |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 3.50e-03 | 85 | 105 | 3 | DOID:9744 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CGSCWAFSSVGALEG | 136 | P43235 | |
| CSSAAGAGAAGVSEW | 41 | Q9NR09 | |
| DQGSCGSCWAFGAVE | 101 | P07858 | |
| GSCWAFSATGALEGQ | 136 | O60911 | |
| ANAGCIAWEGGHGEF | 61 | Q99581 | |
| ACDAWAGGKAGSAVI | 356 | P52824 | |
| NVGSGSKGSDAACWA | 326 | Q86Y34 | |
| SWDQGFCQALGSALG | 366 | Q17RM4 | |
| QQGGAADCWFLAALG | 86 | Q6MZZ7 | |
| CGVADGEGFLSIWQV | 2821 | Q8TDJ6 | |
| GWGNNDCSHSEDVGV | 666 | Q9NR16 | |
| NSGCTGGEASLWDCI | 756 | Q9NR16 | |
| DAILCVAGGWAGGNA | 81 | P09417 | |
| FCGTTEFASGQWAGI | 301 | Q8N3C7 | |
| GEANGKDAESSGCWG | 796 | Q9UQB3 | |
| GSQVSGSCWTGAGAV | 1551 | Q5H9R4 | |
| EFEDQACGGGSWAGA | 1661 | Q5H9R4 | |
| AGGVDIGSWFCAGNE | 1941 | Q5H9R4 | |
| QAGNWSECSTTCGLG | 1416 | Q9UKP4 | |
| TGCAVLNGEGHVFVW | 346 | Q96I51 | |
| GAWPEAGGQSATCEE | 551 | A6NNM3 | |
| GAWPEAGGQSATCEE | 551 | A6NJZ7 | |
| CSRGVQDSGGSEVAW | 161 | Q6NTE8 | |
| TEGGCSLGAQAGWRT | 46 | Q5SY85 | |
| CNAGVGRSTAAVCGW | 266 | O95278 | |
| AGQVVTIWAAGAGAT | 491 | P02545 | |
| ESSLDQCGSNGWGVS | 106 | Q96JB6 | |
| QCGSNGWGVSDCSHS | 111 | Q96JB6 | |
| FTVGGSTSLNGQCEW | 2296 | P46531 | |
| ANTIVCNSKDGGAWG | 56 | P09382 | |
| SGNDFCIWCEVGGHT | 716 | Q16288 | |
| EAGHGLWGETCTNAV | 436 | Q8NE63 | |
| GWALGGGAEFTTACD | 156 | Q9NTX5 | |
| EEAGTSQAGWACGRT | 626 | Q5VZ46 | |
| NEATLAACTSNGWGV | 131 | Q9Y4K0 | |
| IDGATALWCAAGAGH | 86 | Q9UK73 | |
| QEGAEGGQGCSEAWA | 291 | P29376 | |
| SCSDSGLWAVEGGNK | 241 | Q9UHG3 | |
| NLSAVATGNWGCGAF | 861 | Q86W56 | |
| ACAVGSEGVIGWTQA | 261 | Q5T1M5 | |
| VVASPGSGAWEACSN | 231 | O75949 | |
| DGQDACGSNSWTVVD | 546 | P06213 | |
| GWVQGADGLCSVDQG | 1281 | Q9BZA7 | |
| TQWEASGFCVNGDVG | 751 | Q6IE36 | |
| CINTEWGAFGDDGSL | 256 | P19367 | |
| WGQSLAFSGAALGCS | 131 | Q96P69 | |
| GWCVQEDFISGGSRS | 66 | P26012 | |
| ASWQAVTGGCGGIFQ | 1501 | O60494 | |
| RAAGGGASWELCAGA | 11 | Q9UP38 | |
| AWSIDGTQIAGACGN | 276 | Q9P2H3 | |
| FAVGGWCSGDAISSV | 321 | Q9Y2M5 | |
| QVQKSGASGSWDCGL | 451 | Q99704 | |
| WSGQSAGGCGNFQET | 696 | Q9Y6W3 | |
| FSESGCQGSGREVWG | 991 | Q8N1P7 | |
| AGAWSAQIAALAGVG | 291 | Q96CU9 | |
| TTQEDCCGSVGAFWG | 571 | Q14767 | |
| GIVSWGSMNCGEAGQ | 651 | O00187 | |
| WQTGAGCDAAGFFTV | 436 | P23945 | |
| AGVSNWGGYALACAL | 516 | Q7Z3D6 | |
| GDSTETGGCQAWGAA | 86 | Q7Z7M8 | |
| TGGCQAWGAAAATEI | 91 | Q7Z7M8 | |
| ATVEAGTRCQVAGWG | 141 | P20160 | |
| LAFLCGGSGDQAEWN | 616 | Q6P3S1 | |
| VVDSWQSAVCGAFAG | 176 | Q70HW3 | |
| ANGTGATEPCTDGWI | 96 | Q4U2R8 | |
| TQGLSCAWGAAVALG | 601 | Q5FWE3 | |
| VEWNGGVSGRASFCG | 546 | Q07866 | |
| GQGTICWVDCGDAES | 76 | Q14554 | |
| STGQGLAALSEQGWC | 216 | P98161 | |
| AGTACAIAGWGALFE | 221 | P0CW18 | |
| QDWACSVAGTSLGGE | 11 | Q8TE04 | |
| VGFTGCAFGSAAIWQ | 106 | Q9H300 | |
| GSAVGSCLVSEGNSW | 1136 | P11717 | |
| TEAWGCAATQASNSG | 476 | Q9HCJ0 | |
| GCSWESGRAENGVTG | 276 | Q7Z6J9 | |
| AAAASWGQASGPGSC | 451 | Q9BXQ6 | |
| CINTEWGAFGDDGAL | 256 | Q2TB90 | |
| WGCTVVAAGLSGVAG | 11 | Q9HB63 | |
| NVWEASGNRSGGVCD | 346 | Q9HB63 | |
| GAWPEAGGQSATCEE | 551 | Q9UFD9 | |
| IVSWGQGCATVGHFG | 421 | P08709 | |
| WDCAQSQGSVGLAGV | 416 | Q9Y6C5 | |
| GTAGADDCWQGVNGS | 446 | Q2M3G4 | |
| LVAGGCAGVLAWAVA | 221 | Q6Q0C1 | |
| VFADVQEGGTCNASW | 176 | P35346 | |
| CCGEVQSGTFQGAWL | 1596 | Q99466 | |
| TLWCGVGDSAGNSSE | 156 | Q9NZ20 | |
| NWQTACGAATVRGGA | 86 | Q9NPE6 | |
| SGCAFWAGSVVIAAG | 96 | Q3YBM2 | |
| GSCWAFSATGALEGQ | 136 | P07711 | |
| GGINWSEIEAAGFCV | 216 | Q9BWW9 | |
| GGEGALETCSAVGWA | 141 | Q9H2G4 | |
| GQWQACEGLGAAAAR | 351 | A2A3L6 | |
| EFLIGGQASGWCSEG | 256 | P20142 | |
| GQASGWCSEGCQAIV | 261 | P20142 | |
| GVVFGLWSACASVGN | 176 | Q8NCC5 | |
| GSHFCGGSLIAEQWV | 56 | Q9BQR3 | |
| SGFWECRVSTSGGQD | 421 | P35590 | |
| EAICLGQGWAAAATS | 536 | O75717 | |
| NSSVGDLGVGGCSLW | 36 | Q7L0L9 | |
| AVTGWQAGAAHTCSD | 811 | O15015 | |
| FLAGIVSWGIGCAEA | 401 | Q7Z410 | |
| NDTVTPGWGACEGLA | 406 | P55017 | |
| GFGESLKAGSSWQCD | 651 | P49790 | |
| VGWAGNGNVCGTDTD | 446 | P49746 | |
| VLDCGAAPGAWSQVA | 76 | Q9UI43 | |
| GSHFCGGSLISEQWV | 101 | P35030 | |
| AAGTECLISGWGNTL | 191 | P35030 | |
| CLISGWGNTLSFGAD | 196 | P35030 | |
| DWKNSVISGCITGGA | 151 | Q9Y584 | |
| AVGGDESTAGWAQGC | 261 | Q8TF50 | |
| AACLESAQEPSGAWG | 51 | Q00341 | |
| ALNATIGWNGEATCG | 681 | Q9C0I4 | |
| SHSACTWQGGALIAG | 536 | O60294 | |
| DGATAAWQDGPGCDV | 616 | Q5H8A4 | |
| CSGAQGDWSAGLEVD | 111 | Q6ZRP0 | |
| DGRSCWCVGANGSEV | 66 | P01266 | |
| KGSNCQGGWEDDSAA | 796 | Q8NDV7 | |
| RNVEGGSGVTDCWAC | 181 | P30518 | |
| QDGGLVWECSAGHTF | 106 | Q9BU19 | |
| IAASGHFICVGTWSG | 126 | Q9H977 | |
| GCLQQDGSGSFEHWG | 36 | Q9NR64 | |
| GDQCQVAGWGTTAAR | 166 | O43240 | |
| GSCFWVAVLDGNVVG | 181 | Q8N9F0 |